Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daridorexant 50 mg vs placebo in Chinese adults and elderly with insomnia disorder (Phase 3)
CTR20232583Phase 3Completed
- Sponsor
- Idorsia
- Start
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of daridorexant in Insomnia, sponsored by Idorsia. Started Aug 2023; status: completed.
02
Drugs
daridorexant
03
Conditions
Insomnia
Beyond the preview
Go deeper on CTR20232583.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20232583.